Skip to main content
. 2017 Jun 8;80(6):1883–1892. doi: 10.1021/acs.jnatprod.7b00189

Figure 1.

Figure 1

Structures of alamethicin F50 (1), ortho-F-Pheol alamethicin F50 (2), meta-F-Pheol alamethicin F50 (3), trichokonin VI (4), ortho-F-Pheol trichokonin VI (5), and meta-F-Pheol trichokonin VI (6). The amino acid residue targeted for modification is highlighted in blue, whereas the red residues highlight the difference between alamethicin F50 (1) and trichokonin VI (4).

HHS Vulnerability Disclosure